Skip Navigation

Neuropharmacology and Neurologic Diseases

Researchers in the Yerkes Division of Neuropharmacology and Neurologic Diseases are working to advance the understanding of the active human brain through studies focusing on the development and function of the nervous system and anatomical differences seen when neurological disorders are present. Faculty in the Division use interdisciplinary approaches in nonhuman primate models to study a variety of translational problems in neuroscience, including neurodegenerative diseases (Alzheimer's, Parkinson’s, Huntington’s), basal ganglia and motor function, neurobiology of drug addiction, and evolutionary biology. Our long-term goal is to develop the knowledge necessary for improved treatment of specific neurological and psychiatric disorders. Research techniques include behavioral models, neuropharmacology, neurochemistry, neuroanatomical mapping, electrophysiology, in vivo microdialysis, gene expression and profiling, transgenic models, optogenetics and functional brain imaging.

The Yerkes Imaging Core plays a fundamental role in the Division, and all faculty within the Imaging Core have appointments as Core Scientists or Affiliate Scientists within the Division.

Each scientist provides expertise to internal and external (regional, national and international) investigators seeking consultation or requesting use of Yerkes Research Center resources. In addition, the Core Scientists are an integral part of the training and scientific community at Emory University with commitments to provide undergraduate, graduate and postdoctoral training and education, and to foster productive and successful collaborative relations with other investigators on the Emory campus.

In addition to the Division Chief, Leonard L. Howell, PhD, scientists for the division are Anthony W.S. Chan, DVM, PhD, Jonathan Nye, PhD, Todd M. Preuss, PhD, Yoland Smith, PhD, Lary C. Walker, PhD, and Thomas Wichmann, MD.

Division Researchers